Awareness of Gadolinium Toxicity Among Non-radiologists in Saudi Arabia.

Introduction and aim Gadolinium toxicity has been accompanied by side effects among patients scanned with MRI, especially patients with chronic renal insufficiency. The toxicity, pharmacokinetics, and pharmacodynamics of gadolinium-based contrast agents intact blood-brain barriers accumulate in the brain. This study aimed to estimate the awareness about the side effects of gadolinium-enhanced MRI scans among Saudi non-radiologists to improve and raise the level of awareness of all physicians about the side effects of gadolinium-enhanced MRI studies among patients.